Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-22

Clinical Trial Update: A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas

View source ↗

Summary

This report presents a retrospective analysis of raltegravir use in minority HIV-infected women in Houston, Texas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: HIV Infection | Status: UNKNOWN